MX363558B - Composiciones farmaceuticas que comprenden flurbiprofeno. - Google Patents

Composiciones farmaceuticas que comprenden flurbiprofeno.

Info

Publication number
MX363558B
MX363558B MX2015002946A MX2015002946A MX363558B MX 363558 B MX363558 B MX 363558B MX 2015002946 A MX2015002946 A MX 2015002946A MX 2015002946 A MX2015002946 A MX 2015002946A MX 363558 B MX363558 B MX 363558B
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
flurbiprofen
include flurbiprofen
cough
nsaid
Prior art date
Application number
MX2015002946A
Other languages
English (en)
Other versions
MX2015002946A (es
Inventor
Shea Tim
Shephard Adrian
Smith Gary
Aspley Sue
P Schachtel Bernard
Original Assignee
Reckitt Benckiser Healthcare International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47137098&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX363558(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Reckitt Benckiser Healthcare International Ltd filed Critical Reckitt Benckiser Healthcare International Ltd
Publication of MX2015002946A publication Critical patent/MX2015002946A/es
Publication of MX363558B publication Critical patent/MX363558B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención actual proporciona un NSAID tal como ibuprofeno o flurbiprofeno, o una sal farmacéuticamente aceptable del mismo para uso en el tratamiento tópico de tos, especialmente tos seca.
MX2015002946A 2012-09-07 2013-09-09 Composiciones farmaceuticas que comprenden flurbiprofeno. MX363558B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261697901P 2012-09-07 2012-09-07
GBGB1215988.5A GB201215988D0 (en) 2012-09-07 2012-09-07 Pharmaceutical compositions comprising flurbiprofen
PCT/US2013/058685 WO2014039939A1 (en) 2012-09-07 2013-09-09 Pharmaceutical compositions comprising flurbiprofen

Publications (2)

Publication Number Publication Date
MX2015002946A MX2015002946A (es) 2015-06-02
MX363558B true MX363558B (es) 2019-03-27

Family

ID=47137098

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015002946A MX363558B (es) 2012-09-07 2013-09-09 Composiciones farmaceuticas que comprenden flurbiprofeno.

Country Status (12)

Country Link
US (5) US20150231063A1 (es)
EP (1) EP2892528B1 (es)
KR (2) KR20200131913A (es)
AU (1) AU2013312259B2 (es)
BR (1) BR112015004115A2 (es)
ES (1) ES2742034T3 (es)
GB (1) GB201215988D0 (es)
MX (1) MX363558B (es)
PL (1) PL2892528T3 (es)
RU (2) RU2015112586A (es)
WO (1) WO2014039939A1 (es)
ZA (1) ZA201501553B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5025019A (en) * 1984-04-09 1991-06-18 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US5322689A (en) * 1992-03-10 1994-06-21 The Procter & Gamble Company Topical aromatic releasing compositions
US20030206942A1 (en) 1998-09-25 2003-11-06 Neema Kulkarni Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent
US6846495B2 (en) * 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
US20060241175A1 (en) * 2002-09-27 2006-10-26 Joseph Schwarz Vehicle for topical delivery of anti-inflammatory compounds
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
PL2106258T3 (pl) * 2006-10-20 2012-11-30 Bayer Consumer Care Ag Ibuprofen przeciwko kaszlowi
GB2453770A (en) * 2007-10-19 2009-04-22 Reckitt Benckiser Healthcare Oral composition comprising a cooling agent
JP5877204B2 (ja) * 2010-09-29 2016-03-02 パルマトリックス，インコーポレイテッド 吸入用の一価金属カチオン乾燥粉末
GB201021267D0 (en) * 2010-12-15 2011-01-26 Reckitt Benckiser Healthcare Int Ltd Novel pharmaceutical formulation

Also Published As

Publication number Publication date
WO2014039939A1 (en) 2014-03-13
GB201215988D0 (en) 2012-10-24
US20200163871A1 (en) 2020-05-28
US20180110723A1 (en) 2018-04-26
US20220008331A1 (en) 2022-01-13
RU2019102890A (ru) 2019-05-07
BR112015004115A2 (pt) 2017-07-04
AU2013312259B2 (en) 2018-06-07
KR20150048890A (ko) 2015-05-07
KR20200131913A (ko) 2020-11-24
PL2892528T3 (pl) 2019-11-29
EP2892528A1 (en) 2015-07-15
ZA201501553B (en) 2017-08-30
RU2015112586A (ru) 2016-10-27
ES2742034T3 (es) 2020-02-12
EP2892528A4 (en) 2016-04-13
MX2015002946A (es) 2015-06-02
US20150231063A1 (en) 2015-08-20
AU2013312259A1 (en) 2015-04-09
EP2892528B1 (en) 2019-05-15
US20190070101A1 (en) 2019-03-07

Similar Documents

Publication Publication Date Title
DOP2020000102A (es) Compuestos útiles para inhibir a cdk7
GT201400111A (es) Triazolopiridinas sustituidas
CL2015000829A1 (es) Inhibidores de histona desmetilasas
CL2013001338A1 (es) Compuestos derivados de benzotieno-piridinas sustituidas, inhibidores de la replicacion del vih; composicion farmaceutica que los comprende; combinacion farmaceutica; kit farmaceutico; y su uso para el tratamiento del vih.
CL2013002417A1 (es) Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
CR20140318A (es) Composiciones intranasales de dexmedetomidina y métodos de uso de ellas
MX367037B (es) Composiciones para el cuidado bucal y metodos de uso.
GT201700023A (es) Derivados de heterociclico opcionalmente condensados de piridimina útiles para el tratamiento de enfermedades inflamatorias, metabolicas, oncológicas y autoinmunitarias
AR102203A1 (es) Composiciones para el cuidado oral que comprenden zinc, arginina y serina
CO7250444A2 (es) Uso de seaprose para eliminar biopelículas bacterianas
AR085616A1 (es) Composicion farmaceutica inhalable que comprende glicopirrolato, uso
SV2017005466A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
DOP2015000298A (es) Compuestos nuevos para el tratamiento del cáncer
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
UY36292A (es) Compuestos de tetrahidroquinolina para su uso como inhibidores de bromodominios
CL2014001862A1 (es) Compuestos derivados de morofolinilo sustituido, útiles como inhibidores de mogat-2; composicion farmaceutica que los comprende; uso en el tratamiento de hipertrigliceridemia.
ECSP17015154A (es) Métodos para mejorar el rendimiento miocárdico en pacientes con cirugía de fontan que utilizan composiciones de udenafilo
MX2019007361A (es) Composiciones para el cuidado bucal.
CY1118277T1 (el) Σταθερη φαρμακοτεχνικη μορφη πεξιγανανης
CL2015001502A1 (es) Composición farmacéutica que comprende desloratadina y prendnisolona y uso de la misma.
MX363558B (es) Composiciones farmaceuticas que comprenden flurbiprofeno.
MX383705B (es) Sales de tungsteno (vi) para su uso en el tratamiento de la infertilidad, para favorecer la fertilidad y la reproducción normal en un mamífero hembra no diabético, así como para mejorar la eficacia de las técnicas de reproducción asistida.
CL2016002083A1 (es) Composición antifúngica tópica para el tratamiento de onicomicosis
PE20151432A1 (es) Formulaciones de lorazepam de liberacion sostenida
UY34895A (es) Formulaciones estabilizadas de etanercept